A detailed history of Harbor Investment Advisory, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 400 shares of CDNA stock, worth $9,452. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$9,452
Previous $6,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020

SELL
$30.88 - $37.94 $3,088 - $3,794
-100 Reduced 20.0%
400 $15,000
Q1 2020

May 11, 2020

SELL
$13.94 - $28.25 $1,394 - $2,825
-100 Reduced 16.67%
500 $11,000
Q4 2019

Jan 16, 2020

BUY
$19.24 - $28.41 $11,543 - $17,046
600 New
600 $13,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.